![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Schlitzer M. Sattler I.
Publisher: Pharmaceutical Press
ISSN: 1460-8081
Source: Pharmacy and Pharmacology Communications, Vol.6, Iss.11, 2000-11, pp. : 507-512
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacy and Pharmacology Communications, Vol. 6, Iss. 3, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Non-peptidic chymase inhibitors
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Non-Peptidic HIV Protease Inhibitors
Current Topics in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-06 ,pp. :